AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 12 filers reported holding AZURRX BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $51,000 | +104.0% | 61,601 | +223.7% | 0.00% | – |
| Q1 2021 | $25,000 | +66.7% | 19,029 | +20.1% | 0.00% | – |
| Q4 2020 | $15,000 | +36.4% | 15,848 | +3.3% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 15,338 | +0.0% | 0.00% | – |
| Q2 2020 | $14,000 | -62.2% | 15,332 | -75.5% | 0.00% | – |
| Q1 2020 | $37,000 | -42.2% | 62,706 | +0.9% | 0.00% | – |
| Q4 2019 | $64,000 | +120.7% | 62,154 | +29.9% | 0.00% | – |
| Q3 2019 | $29,000 | -59.7% | 47,842 | +13.1% | 0.00% | – |
| Q2 2019 | $72,000 | +10.8% | 42,313 | +57.6% | 0.00% | – |
| Q1 2019 | $65,000 | +91.2% | 26,850 | -6.4% | 0.00% | – |
| Q4 2018 | $34,000 | -54.7% | 28,684 | -1.8% | 0.00% | – |
| Q3 2018 | $75,000 | -16.7% | 29,208 | +4.2% | 0.00% | – |
| Q2 2018 | $90,000 | +109.3% | 28,029 | +105.2% | 0.00% | – |
| Q1 2018 | $43,000 | -15.7% | 13,662 | -2.5% | 0.00% | – |
| Q4 2017 | $51,000 | -3.8% | 14,012 | +4.2% | 0.00% | – |
| Q3 2017 | $53,000 | -7.0% | 13,452 | -5.4% | 0.00% | – |
| Q2 2017 | $57,000 | – | 14,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pensionmark Financial Group, LLC | 80,000 | $57,000 | 0.02% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 178,203 | $127,000 | 0.01% |
| Traynor Capital Management, Inc. | 24,999 | $20,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 30,000 | $21,000 | 0.00% |
| Waldron Private Wealth LLC | 69,835 | $49,000 | 0.00% |
| Beacon Pointe Advisors, LLC | 39,363 | $28,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 6,250 | $4,000 | 0.00% |
| BlackRock Inc. | 15,338 | $11,000 | 0.00% |
| Bank of New York Mellon Corp | 215,313 | $153,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 800 | $1,000 | 0.00% |